Outcomes of Iris-Claw IOL Implantation in Patients with Marfan's Syndrome in Jordan.

Rami A Al-DwairiWisam A ShihadehAsem A Alqudah Noor M AlqudahMohammed MsallamFiras AlrazemSarah AlshamartiZaki ShannakMohammad AbueidAbdelwahab Aleshawi

Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)

Iris-claw IOL (either anteriorly or retropupillary) is an effective and relatively safe method in treating ectopia lentis in patients with Marfan's syndrome. In younger patients, anterior iris-claw IOL is safer than retropupillary iris-claw IOL as the risk of disenclavation is higher in younger patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
type diabetes
insulin resistance